Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.75987 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.66718 | 29 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.71054 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.62841 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.84329 | 39 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.94789 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.7077 | 29 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.68631 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67652 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.70559 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.69384 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.68365 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.70079 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69866 | 31 |